Visual Inspection of Medications in Preventing Unexplained Relapses

Leverich GS Post RM Rosoff AS . Factors associated with relapse during maintenance treatment of affective disorders. Int Clin Psychopharmacol 1990;5: 135–56.

Bates DW Cullen DJ Laird N Petersen LA Small SD Servi D Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274: 29–34.

DIagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994;424–9.

Bedell SE Jabbour S Goldberg R Glaser H Gobble S Young-Xu Y Discrepancies in the use of medications: Their extent and predictors in an outpatient practice. Arch Intern Med 2000;160: 2129–34.

Johnson KB Butta JK Donohue PK Glenn DJ Holtzman NA . Discharging patients with prescriptions instead of medications: Sequelae in a teaching hospital. Pediatrics 1996;97: 481–5.

Peterson GM Wu MS Bergin JK . Pharmacist's attitudes towards dispensing errors: Their causes and prevention. J Clin Pharm Ther 1999;24: 57–71.

Cohen MR . Drug product characteristics that foster drug-use-system errors. Am J Health Syst Pharm 1995;52: 395–9.

Edgar TA Lee DS Cousins DD . Experience with a national medication errors reporting program. Am J Hosp Pharm 1994;51: 1335–8.

Ladewig D . Abuse of benzodiazepines in a western European society — Incidence and prevalence, motives, drug acquisition. Pharmacopsychiatria 1983;16: 103–6.

American Psychiatric Association. Practice guidelines for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000;15(Suppl):1–45.